ClinicalTrials.gg

Drug

Butylscopolammonium Bromide clinical trials

Also written Buscopan and hyoscine butylbromide.

studies test it
34
open now
4
in phase 3
6
first study started
2005

Keep track of what changes. Save the Butylscopolammonium Bromide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

34 studies that test it; most in 2018 (5)

Studies that test Butylscopolammonium Bromide, by start year
YearStudies
20051
20061
20072
20081
20122
20132
20141
20154
20161
20173
20185
20194
20201
20212
20232
20262

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
4
Phase 3
6
Phase 4
10
No phase
10

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 6 · Other 28

Boehringer Ingelheim (6) · Cairo University (4) · Assiut University (3) · Oslo University Hospital (2) · Ain Shams University (2) · Saglik Bilimleri Universitesi (1) · Centre de recherche du Centre hospitalier universitaire de Sherbrooke (1) · National University of Malaysia (1)

Often tested with

Tested in the same studies.

Ondansetron (2) · Loperamide (1) · Misoprostol (1) · Celecoxib (1) · Sodium Bicarbonate (1) · Bisacodyl (1)

Studies

Open first, then newest update. How each study uses Butylscopolammonium Bromide is read from its arms, and is right about nine times in ten.

Testing it · 34

See all 34 studies that test Butylscopolammonium Bromide →

Given in every arm · 1 — Butylscopolammonium Bromide is usual care beside what is tested
As the comparator · 5 — what is tested is compared with Butylscopolammonium Bromide

Codes

What other systems call Butylscopolammonium Bromide · ClinicalTrials.gg INT007108

  • MeSH (NLM) D002086Butylscopolammonium BromideConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 2Z3E1OF81VBUTYLSCOPOLAMINEConfirmed FDA, NLM
  • RxNorm 1085787One source FDA

Also registered as butylscopolamine bromide (UNII 0GH9JX37C8 · RxNorm 1851).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.